Beyond Covid-19 vaccination-associated pitfalls on [18F]Fluorodeoxyglucose (FDG) PET: a case of a concomitant sarcoidosis

Bauckneht, Matteo; Aloè, Teresita; Tagliabue, Elena; Cittadini, Giuseppe; Guadagno, Antonio; Morbelli, Silvia; Barisione, Emanuela

doi:10.1007/s00259-021-05360-w

Cited by 12 publications

(19 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A literature search revealed one additional case of axillary and pulmonary lymphadenopathy associated with sarcoidosis after vaccination against SARS-CoV-2 [19]. However, we were unable to find other cases of LS associated with the vaccination against SARS-CoV-2.…”

Section: Discussionmentioning

confidence: 67%

First Report of Two Cases of Löfgren’s Syndrome after SARS-CoV-2 Vaccination-Coincidence or Causality?

2021

View full text Add to dashboard Cite

Sarcoidosis can present as an acute form or take a chronic course. One of the acute presentations is Löfgren’s syndrome (LS), consisting of the symptom triad of bilateral hilar lymphadenopathy, erythema nodosum, and ankle periarthritis. In addition, there are occasional reports of sarcoid-like reactions following drug exposures. Nevertheless, reports of sarcoidosis or LS after vaccination have not been published. Here, we report two cases of de novo LS in a temporal association with different vaccines against the new coronavirus SARS-CoV-2. One patient developed the first symptoms three days after the second vaccination (first vaccination ChadOx-1, Astra Zeneca; second vaccination CX-024414, Moderna); in the second patient, symptoms started 28 days after the first vaccination (ChadOx-1, Astra Zeneca). Both patients eventually required treatment with glucocorticoids. Both patients achieved clinical improvement with treatment. In conclusion, we report the first two cases of LS shortly after SARS-CoV-2 vaccination.

show abstract

Section: Discussionmentioning

confidence: 67%

First Report of Two Cases of Löfgren’s Syndrome after SARS-CoV-2 Vaccination-Coincidence or Causality?

2021

View full text Add to dashboard Cite

show abstract

“…Overall, these articles are mainly case reports or small case series recently published by research groups from different countries worldwide reporting PET findings in COVID-19 vaccine recipients who underwent PET/CT or PET/MRI with different radiotracers for several indications [2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21] (Table 1). Most of the described patients underwent vaccination against COVID-19 from 1 day to 3 weeks before 18 F-FDG PET/CT.…”

mentioning

confidence: 99%

PET findings after COVID-19 vaccination: “Keep Calm and Carry On”

Treglia

Cuzzocrea

Muoio

et al. 2021

Clin Transl Imaging

View full text Add to dashboard Cite

“…Interestingly, three patients presented exacerbation of their cutaneous diseases, including a flare of lichen planus, psoriasis and sarcoidosis, already present, and worsened, possibly induced by the vaccine. 25 …”

Section: Discussionmentioning

confidence: 99%

“…Indeed, seborrheic keratosis, eruptive angiomas, acral ecchymoses were interpreted as likely unrelated to the COVID‐19 vaccination and no literature reports were found to support possible causal associations. 25 …”

Section: Discussionmentioning

confidence: 99%

Cutaneous reactions to COVID‐19 vaccine at the dermatology primary care

Burlando

Herzum

Micalizzi

et al. 2021

Immunity Inflam & Disease

View full text Add to dashboard Cite

Introduction: Coronavirus disease 2019 (COVID-19) vaccines can cause adverse reactions, mainly from vaccine-induced immune responses. Some of these may also involve the skin and worry unaware patients. A better understanding of such adverse reactions may reduce concerns and help promote the vaccination of large population groups. Methods: All the reports of patients admitted to our Dermatology Primary Care, from March 2021 to June 2021, were retrospectively examined to collect descriptive data on skin reactions arising after COVID-19 vaccination. Results: Out of 200 vaccinated patients admitted to the Dermatology Primary Care, 21 (10.5%) referred cutaneous reactions with onset after vaccination. Only one patient required hospitalization for generalized bullous erythema multiforme, which occurred 48 h after the second vaccine dose. The other patients' cutaneous reactions to vaccination were of mild/moderate degree.Three patients presented exacerbation of their cutaneous diseases. Conclusions: Cutaneous reactions observed in our sample were mostly mild or moderate. Awareness must be raised to recognize and treat eventual severe reactions. Future studies are needed to assess the incidence of cutaneous reactions following COVID-19 vaccination.

show abstract

Beyond Covid-19 vaccination-associated pitfalls on [18F]Fluorodeoxyglucose (FDG) PET: a case of a concomitant sarcoidosis

Cited by 12 publications

References 11 publications

First Report of Two Cases of Löfgren’s Syndrome after SARS-CoV-2 Vaccination-Coincidence or Causality?

First Report of Two Cases of Löfgren’s Syndrome after SARS-CoV-2 Vaccination-Coincidence or Causality?

PET findings after COVID-19 vaccination: “Keep Calm and Carry On”

Cutaneous reactions to COVID‐19 vaccine at the dermatology primary care

Contact Info

Product

Resources

About